These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 29425176

  • 1. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
    Kim JA, Seong RK, Kumar M, Shin OS.
    Viruses; 2018 Feb 09; 10(2):. PubMed ID: 29425176
    [Abstract] [Full Text] [Related]

  • 2. Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens.
    Pires de Mello CP, Tao X, Kim TH, Bulitta JB, Rodriquez JL, Pomeroy JJ, Brown AN.
    Antimicrob Agents Chemother; 2018 Jan 09; 62(1):. PubMed ID: 29109164
    [Abstract] [Full Text] [Related]

  • 3. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
    Kamiyama N, Soma R, Hidano S, Watanabe K, Umekita H, Fukuda C, Noguchi K, Gendo Y, Ozaki T, Sonoda A, Sachi N, Runtuwene LR, Miura Y, Matsubara E, Tajima S, Takasaki T, Eshita Y, Kobayashi T.
    Antiviral Res; 2017 Oct 09; 146():1-11. PubMed ID: 28818572
    [Abstract] [Full Text] [Related]

  • 4. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
    Pires de Mello CP, Tao X, Kim TH, Vicchiarelli M, Bulitta JB, Kaushik A, Brown AN.
    Antimicrob Agents Chemother; 2018 Sep 09; 62(9):. PubMed ID: 29967017
    [Abstract] [Full Text] [Related]

  • 5. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
    Cai L, Sun Y, Song Y, Xu L, Bei Z, Zhang D, Dou Y, Wang H.
    Arch Virol; 2017 Sep 09; 162(9):2847-2853. PubMed ID: 28597088
    [Abstract] [Full Text] [Related]

  • 6. Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs.
    Bassi MR, Sempere RN, Meyn P, Polacek C, Arias A.
    Antimicrob Agents Chemother; 2018 Sep 09; 62(9):. PubMed ID: 29914957
    [Abstract] [Full Text] [Related]

  • 7. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D, Park JG, Ávila-Pérez G, Nogales A, de la Torre JC, Almazan F, Martinez-Sobrido L.
    Viruses; 2020 Sep 18; 12(9):. PubMed ID: 32961956
    [Abstract] [Full Text] [Related]

  • 8. Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals.
    Lanko K, Eggermont K, Patel A, Kaptein S, Delang L, Verfaillie CM, Neyts J.
    Antiviral Res; 2017 Sep 18; 145():82-86. PubMed ID: 28736077
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of geographically and temporally distinct Zika viruses to favipiravir and ribavirin.
    Baz M, Goyette N, Griffin BD, Kobinger GP, Boivin G.
    Antivir Ther; 2017 Sep 18; 22(7):613-618. PubMed ID: 28694390
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
    Vicenti I, Boccuto A, Giannini A, Dragoni F, Saladini F, Zazzi M.
    Virus Res; 2018 Jan 15; 244():64-70. PubMed ID: 29113824
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS, Chu YK, Golden JE, Chung DH.
    Antiviral Res; 2017 Feb 15; 138():47-56. PubMed ID: 27919709
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol affects Zika virus replication in vitro.
    Mohd A, Zainal N, Tan KK, AbuBakar S.
    Sci Rep; 2019 Oct 04; 9(1):14336. PubMed ID: 31586088
    [Abstract] [Full Text] [Related]

  • 13. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
    de Souza AAA, Torres LR, Capobianco LRPL, de Paula VS, Cascabulho CM, Salomão K, Bonecini-Almeida MDG, Ferreira MLG, Boechat N, Pinheiro LCDS, de Souza EM.
    Viruses; 2020 Dec 29; 13(1):. PubMed ID: 33383619
    [Abstract] [Full Text] [Related]

  • 14. Suppression of Zika Virus Infection and Replication in Endothelial Cells and Astrocytes by PKA Inhibitor PKI 14-22.
    Cheng F, Ramos da Silva S, Huang IC, Jung JU, Gao SJ.
    J Virol; 2018 Feb 15; 92(4):. PubMed ID: 29212931
    [Abstract] [Full Text] [Related]

  • 15. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
    Loe MWC, Lee RCH, Chu JJH.
    Antiviral Res; 2019 Dec 15; 172():104637. PubMed ID: 31669333
    [Abstract] [Full Text] [Related]

  • 16. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
    Tong X, Smith J, Bukreyeva N, Koma T, Manning JT, Kalkeri R, Kwong AD, Paessler S.
    Antiviral Res; 2018 Jan 15; 149():34-40. PubMed ID: 29126899
    [Abstract] [Full Text] [Related]

  • 17. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
    Esser-Nobis K, Aarreberg LD, Roby JA, Fairgrieve MR, Green R, Gale M.
    J Virol; 2019 Jul 01; 93(13):. PubMed ID: 31019057
    [Abstract] [Full Text] [Related]

  • 18. Cinnamic acid inhibits Zika virus by inhibiting RdRp activity.
    Chen Y, Li Z, Pan P, Lao Z, Xu J, Li Z, Zhan S, Liu X, Wu Y, Wang W, Li G.
    Antiviral Res; 2021 Aug 01; 192():105117. PubMed ID: 34174248
    [Abstract] [Full Text] [Related]

  • 19. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment.
    Riva L, Goellner S, Biering SB, Huang CT, Rubanov AN, Haselmann U, Warnes CM, De Jesus PD, Martin-Sancho L, Terskikh AV, Harris E, Pinkerton AB, Bartenschlager R, Chanda SK.
    J Virol; 2021 Oct 27; 95(22):e0099621. PubMed ID: 34468177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.